PAVmed Inc. Reports Results for Quarter Ended June 30, 2026

What Happened

• On August 14, 2026, PAVmed Inc. announced its financial results and provided a business update for the fiscal quarter ended June 30, 2026 via a press release.
• The company filed this information on Form 8-K (Item 2.02) and furnished the disclosure under Regulation FD (Item 7.01). The press release is attached as Exhibit 99.1 to the filing.

Key Details

• Filing date: August 14, 2026.
• Reporting period: fiscal quarter ended June 30, 2026.
• Disclosure format: press release attached as Exhibit 99.1 to the Form 8-K.
• Regulation FD: the company identified the disclosure as furnished under Item 7.01 (broad public dissemination).

Why It Matters

• This 8-K is the company’s public announcement of its latest quarterly operating and financial results and any related business developments — primary information investors use to assess near-term performance.
• Because the information was furnished under Regulation FD, it was broadly released to the market rather than provided selectively.
• Investors should read the attached press release (Exhibit 99.1) for the specific financial figures, operational highlights, and any commentary on guidance or cash/runway; expect fuller financial detail and management discussion in the upcoming quarterly report (Form 10-Q).